NEW YORK (
CHANGE IN RATINGS
Anadarko (APC) was upgraded at Argus to buy from hold. Twelve-month price target is $96. The company can deliver solid production growth through the end of the decade, Argus said.
Auxilium (AUXL) was downgraded at Morgan Stanley to underweight. This is a valuation call based on a $15 12-month price target, Morgan Stanley said..
Axiall (AXLL) was upgraded at Goldman Sachs to buy. Twelve-month price target of $60. Bad news is largely priced in and peak earnings could double, said Goldman Sachs.Biogen Idec (BIIB) was upgraded at BMO Capital to outperform. Twelve-month price target is $422. The company has attractive near-term growth opportunities in its product pipeline, BMO said. Bob Evans (BOBE) was upgraded to buy from hold at Miller Tabak. Twelve-month price target of $58. Visibility is improving for an earnings turnaround, said Miller Tabak. Brixmor Property Group (BRX) was downgraded to neutral from buy at UBS. Twelve-month price target of $21.50. This was a valuation call, with retail sentiment headwinds remaining, UBS said. Continental Resources (CLR) was downgraded to neutral from buy at UBS. Twelve-month price target of $130. This is a valuation call due to the slowdown in NAV growth, said UBS.